Secondary outcomes include : ( i ) relapse time interval , ( ii ) time to onset , ( iii ) rebound rate , ( iv ) PASI score , ( v ) cumulative consumption of medicine , ( vi ) the dermatology quality life index ( DLQI ) , and ( vii ) the medical outcomes study ( MOS ) item short form health survey ( SF-36 ) .